URGN
UroGen Pharma (URGN)
$96
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$48.19
Daily low
$45.75
Price at open
$47.23
52 Week High
$48.19
52 Week Low
$15.86
Market cap
2.2B
Dividend yield
0.00%
Volume
1.0M
Avg. volume
857,493
P/E ratio
-22.87
UroGen Pharma News
Details
Daily high
$48.19
Daily low
$45.75
Price at open
$47.23
52 Week High
$48.19
52 Week Low
$15.86
Market cap
2.2B
Dividend yield
0.00%
Volume
1.0M
Avg. volume
857,493
P/E ratio
-22.87